MAD2L2 and melanoma: Hoshino et al. showed that high REV-7 expression in malignant melanomas was associated with increased cancer cell proliferation, and that the inactivation of REV-7 in melanoma cells resulted in increased chemosensitivity to cisplatin but not to dacarbazine [19].